Benign Neoplasm
9
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Fluid Challenge and Plasma Volume, During Surgery
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders
Virtual Surgical Planning in Mandibular Segmental Resection
Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Role of PET/MRI in Head and Neck Cancer
Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors